Earnings (Loss) per Share - Computation (Details) - P3 Health Partners Inc. - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 11 Months Ended | 12 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 02, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||||||||||||
Financial Designation, Predecessor and Successor [Fixed List] | Successor | Successor | Successor | Predecessor | Predecessor | Successor | Predecessor | Predecessor | Predecessor | Predecessor | ||||
Numerator - Basic: | ||||||||||||||
Net loss | $ (57,937,929) | $ (903,105,939) | $ (29,464,410) | $ (24,650,712) | $ (963,896,193) | $ (54,115,119) | $ (146,399,938) | $ (31,411,542) | $ (41,971,558) | |||||
LESS NET LOSS ATTRIBUTABLE TO NON-CONTROLLING INTERESTS | (47,856,729) | (748,755,990) | (798,968,740) | |||||||||||
Net loss attributable to Class A common stockholders - Basic | (10,081,200) | (154,349,949) | (164,927,453) | |||||||||||
Numerator - Diluted: | ||||||||||||||
Net loss attributable to Class A common stockholders - Basic | (10,081,200) | (154,349,949) | (164,927,453) | |||||||||||
Add: Net loss and tax effect attributable to Non-controlling interest | (47,856,729) | (748,755,990) | (798,968,740) | |||||||||||
Net loss attributable to Class A common stockholders - Diluted | $ (10,081,200) | $ (903,105,939) | $ (963,896,193) | |||||||||||
Denominator - Basic: | ||||||||||||||
Weighted average Class A common shares outstanding - Basic | 41,578,890 | 41,578,890 | 41,578,890 | |||||||||||
Loss per share attributable to Class A common shareholders - Basic | $ (0.24) | $ (3.71) | [1] | $ (3.97) | [1] | |||||||||
Denominator - Diluted: | ||||||||||||||
Weighted average Class A common shares outstanding - Basic | 41,578,890 | 41,578,890 | 41,578,890 | |||||||||||
Weighted average effect of dilutive Class V shares | 200,473,866 | 198,782,864 | ||||||||||||
Weighted average Class A common shares outstanding - Diluted | 41,578,890 | 242,052,756 | 240,361,754 | |||||||||||
Loss per share attributable to Class A common shareholders - Diluted | $ (0.24) | $ (3.73) | [1] | $ (4.01) | [1] | |||||||||
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity. Acceptable values are "Predecessor" and "Successor". Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|